The largest database of trusted experimental protocols

Latex agglutination

Manufactured by Statens Serum Institut
Sourced in Denmark

Latex agglutination is a laboratory test that uses latex particles coated with specific antibodies to detect the presence of certain antigens or antibodies in a sample. The test relies on the principle of agglutination, where the binding of the antigen to the antibody-coated latex particles causes the particles to clump together, or agglutinate. The degree of agglutination is used to determine the presence and, in some cases, the quantity of the target analyte in the sample.

Automatically generated - may contain errors

7 protocols using latex agglutination

1

Pneumococcus Isolation from Saliva

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cultured-enriched saliva samples in which a higher concentration of pneumococcus was detected (<30 Ct by qPCR) were re-visited in an attempt to isolate pure pneumococcus. Samples were serially diluted 10-fold over a range of 10−1 to 10−5 in 1X PBS. The 10−5 and 10−6 serially diluted samples were plated (100 μL) onto plain blood agar plates. After overnight incubation, culture plates were visually screened for pneumococcal-like colonies. Each colony of pneumococcus-like morphology was streaked onto a plain blood agar plate and then inoculated into 50 μL of elution buffer (ThermoFisher Scientific) in a microcentrifuge tube. From each saliva sample, a total of 20 colonies were streaked onto one plain blood agar plate, with colonies pooled by 5 in each microcentrifuge tube. Pooled bacterial colonies were incubated for 10 min at 95°C on a heating block, then tested in qPCR for piaB and lytA to confirm the identity of the isolates. Streaked isolates from the pooled boilate samples that generated any signal <40 Ct for either piaB or lytA were individually tested for optochin susceptibility. Optochin susceptible colonies which tested positive for both piaB and lytA were then serotyped by latex agglutination (Statens Serum Institut) (39 (link)).
+ Open protocol
+ Expand
2

Bacterial Serotyping via Latex Agglutination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolates were cultured onto Columbia agar plates supplemented with horse blood (Oxoid Ltd., Hampshire, UK) and incubated aerobically at 37 °C for 24 h. Serological classification based on capsular polysaccharide types Ia, Ib and II to IX was performed using latex agglutination according to the manufacturer’s recommendations (Statens Serum Institute, Copenhagen, Denmark).
+ Open protocol
+ Expand
3

Identification and Serotyping of GBS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Standard laboratory methods for the identification of GBS on culture have been described [12 (link)]. Briefly, GBS from blood was isolated using the Bact/Alert microbial system (Organon Teknika, Durham, NC), plated on blood or chocolate agar. On CSF samples, gram-staining was done and samples plated onto blood or chocolate agar plates were inoculated into an enrichment broth (Brain Heart Infusion, Diagnostics Media Production; South Africa). A GBS antigen agglutination test (Wellcogen Bacterial Antigen Kit, Remel, UK) was also undertaken if the CSF culture was negative, but the CSF cyto-chemistry was suggestive of bacterial meningitis. Positive GBS isolates were archived at -70 degrees celsius at the Respiratory and Meningeal Pathogens Research Unit. Serotyping (Ia, Ib, II–IX) methods were consistently performed over the study period using latex agglutination (Statens Serum Institute, SSI, Sweden) [20 (link), 21 (link)]. Twelve (1.9%) non-typeable isolates were further characterized using single-plex PCR and primers as described (S1 Table) [22 (link), 23 (link)].
+ Open protocol
+ Expand
4

Intranasal Pneumococcus Colonization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Volunteers were enrolled from clinical studies conducted between 2016 and 2019. Details on study design have been previously described (36 (link)). Ethical approval was given by local NHS Research and Ethics Committee (REC) (14/NW/1460, 18/NW/0481, 15/NW/0931), and the clinical trial was registered on the European Clinical Trials Database (EudraCT, 2014-004634-26 and ISRCTN22467293). All experiments conformed to the relevant regulatory standards (Human Tissue Act, 2004). Informed consent was obtained from all volunteers.
Briefly, volunteers were screened for S. pneumoniae colonization (natural carriers) and were intranasally inoculated with the S. pneumoniae 6B serotype (strain BHN418; GenBank accession number ASHP00000000.1) at 8 × 104 CFU/100 μl per nostril. Colonization was assessed by classical microbiology culture in nasal washes collected at 2, 6, 9, 14, 21, and 27 days post exposure, and serotype was confirmed by latex agglutination (Statens Serum Institut, Copenhagen, Denmark). Colonization results were confirmed by S. pneumoniae 6A/B capsule-specific and lytA-specific qPCR on nasal wash pellet as described below. Volunteers enrolled in home sampling were not vaccinated against S. pneumoniae.
+ Open protocol
+ Expand
5

Genetic Modification of Bacterial Serotypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cps locus of isolates was first knocked out using a Janus cassette [48 (link)] as described previously [49 (link)]. Transformation was conducted using genomic DNA from the serotype donor and the competence stimulating peptide appropriate to the genotype. After 2 h growth, selection was performed using plates containing 500 μg ml-1 streptomycin. Colonies were replica plated to ensure loss of kanamycin resistance and expression of the altered serotype confirmed through latex agglutination (Statens Serum Institut, Copenhagen).
+ Open protocol
+ Expand
6

Pneumococcal Inoculation and Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pneumococcal stock preparation and inoculation were performed as previously described [19 (link)]. Briefly, a serotype 6B clinical isolate (BHN418) [20 (link)] was grown to an optical density at 600 nm of 0.2–0.3 in Vegitone broth (Oxoid, Basingstoke, UK), and stored in 1-mL aliquots containing 10% glycerol at −80°C. Serotype confirmation was performed by latex agglutination (Statens Serum Institute, Copenhagen, Denmark), and bacterial stock purity and penicillin sensitivity were confirmed by an independent reference laboratory (Public Health England, London, UK). Eighty-four volunteers received a pneumococcal inoculation of between 10 000 and 320 000 CFUs per naris.
+ Open protocol
+ Expand
7

Pneumococcus Isolation from Saliva

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cultured-enriched saliva samples in which a higher concentration of pneumococcus was detected (<30 Ct by qPCR) were re-visited in an attempt to isolate pure pneumococcus. Samples were serially diluted 10-fold over a range of 10−1 to 10−5 in 1X PBS. The 10−5 and 10−6 serially diluted samples were plated (100 μL) onto plain blood agar plates. After overnight incubation, culture plates were visually screened for pneumococcal-like colonies. Each colony of pneumococcus-like morphology was streaked onto a plain blood agar plate and then inoculated into 50 μL of elution buffer (ThermoFisher Scientific) in a microcentrifuge tube. From each saliva sample, a total of 20 colonies were streaked onto one plain blood agar plate, with colonies pooled by 5 in each microcentrifuge tube. Pooled bacterial colonies were incubated for 10 min at 95°C on a heating block, then tested in qPCR for piaB and lytA to confirm the identity of the isolates. Streaked isolates from the pooled boilate samples that generated any signal <40 Ct for either piaB or lytA were individually tested for optochin susceptibility. Optochin susceptible colonies which tested positive for both piaB and lytA were then serotyped by latex agglutination (Statens Serum Institut) (39 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!